Celecoxib Prevents Doxorubicin-Induced Multidrug Resistance in Canine and Mouse Lymphoma Cell Lines.
Edina KaraiKornélia SzebényiTímea WindtSára FehérEszter SzendiValéria DékayPéter VajdovichGergely SzakácsAndrás FürediPublished in: Cancers (2020)
Our findings suggest that celecoxib could significantly improve the efficiency of chemotherapy by preventing the development of MDR in B-cell lymphoma.